Alternative titles and symbols : Vacuolar cardiomyopathy and myopathy, X-linked; Gsd iib; Antopol disease; Glycogen storage disease iib; Pseudoglycogenosis II; Lysosomal glycogen storage disease without acid maltase deficiency; GSD2B;
Description : Danon disease is an X-linked dominant disorder predominantly affecting cardiac muscle.
Skeletal muscle involvement and mental retardation are variable features. The accumulation
of glycogen in muscle and lysosomes originally led to the classification of Danon
disease as a variant of glycogen storage disease II (Pompe disease; 232300) with 'normal
acid maltase' or alpha-glucosidase (GAA; 606800) (Danon et al., 1981). However, Nishino
et al. (2000) stated that Danon disease is not a glycogen storage disease because
glycogen is not always increased. Sugie et al. (2005) classified Danon disease as
a form of autophagic vacuolar myopathy, characterized by intracytoplasmic autophagic
vacuoles with sarcolemmal features. The characteristic vacuole is believed to be an
autolysosome surrounded by secondarily-generated membranes containing sarcolemmal
proteins, basal lamina, and acetylcholinesterase activity. X-linked myopathy with
excessive autophagy (XMEA; 310440) is a distinct disorder with similar pathologic
features.;
Inheritance : X-linked dominant;
Molecular basis : Caused by mutation in the lysosome associated membrane protein-2 gene (LAMP2, 309060.0001);